FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
Share This Story
PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
Share This Story
Yajaira Johnson-Esparza, PhD, licensed clinical psychologist and clinical associate professor, Department of Family and Community Medicine, was interviewed for this news segment. Watch Now: KVDA-TV: Cómo afecta la diabetes y el bienestar emocional, según experta – Telemundo San Antonio (60) Watch Now: KVDA-TV YouTube: La conexión entre la diabetes y el bienestar emocional. | […]
Share This Story
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of death for people with Type 2 diabetes and people with diabetes are more than twice as likely to experience a heart attack or stroke, according to the American Diabetes Association. While most cardiologists focus on […]
Share This Story
This story is featured in the April 2025 Bexar County Medical Society’s San Antonio Medicine magazine About one in 10 Texans is living with Type 2 diabetes — one of the highest rates of the disease in the United States. In San Antonio, the rate is one in six people and another third of the […]
Share This Story
Carolina Solis–Herrera, MD, associate professor of medicine and chief of the Division of Endocrinology, was interviewed for this news segment. Watch Now
Share This Story
UT Health San Antonio was mentioned in this news segment. Listen Now
Share This Story
UT Health San Antonio was mentioned in this news segment. Listen Now
Share This Story
UT Health San Antonio was mentioned in this news segment. Read More
Share This Story
Content provided by Claire Kowalick A study published in the International Wound Journal conducted by researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) revealed risk factors for reinfection after treatment of a diabetic foot infection. The study found nearly half of patients who receive treatment for diabetic foot infections will experience […]
Share This Story